NCT04736368

Brief Summary

Crohn's disease is a chronic recurrent systemic inflammatory disease. Studies have shown that meat, dairy products, fiber and vitamin D may affect the risk of Crohn's disease. The relationship between other dietary components and disease activity or recurrence in Chron's disease has not been fully studied. Although the patient's diet will affect the degree of disease activity, there is still no recognized daily diet model for CD patients. At present, the change of intestinal microbiome is considered to be one of the causes of IBD, and this change provides a theoretical basis for diet to reduce the inflammatory response in CD patients through the regulation of microbiome. Food driven inflammation may affect the activity of the disease. Brain-gut axis interaction may play an important role in CD and may have an effect on the cerebrovascular system. The investigators aim to evaluate the effects of Empirical Dietary Inflammatory Pattern (EDIP) based dietary suggestions on disease activity and cerebrovascular function as well as changes of intestinal flora and its metabolites amongst Chron's disease participants of all ages.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2021

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 26, 2021

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

January 31, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 3, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2021

Completed
Last Updated

February 3, 2021

Status Verified

January 1, 2021

Enrollment Period

4 months

First QC Date

January 31, 2021

Last Update Submit

February 2, 2021

Conditions

Keywords

Crohn's DiseaseEDIP dietTherapyCerebrovascular Function

Outcome Measures

Primary Outcomes (1)

  • Chron's Disease Activity Index

    The participants disease activity will be assessed with CDAI index.

    14 weeks post enrollment.

Secondary Outcomes (2)

  • Mucosal Changes

    14 weeks post enrollment.

  • Cerebrovascular Function

    14 weeks post enrollment.

Study Arms (2)

EDIP Group

EXPERIMENTAL

CD participants will receive EDIP diet information

Other: EDIP Diet Suggestions

Control Group

PLACEBO COMPARATOR

CD participants will be given diet suggestions according to routine experience.

Other: diet guidance

Interventions

CD participants will receive EDIP diet suggestions after random allocation.

EDIP Group

Control group will be given diet guidance according to routine experience under the participant's request.

Control Group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants with a confirmed diagnosis of CD were actively included for different treatment strategies.

You may not qualify if:

  • Participants with multi-system organ failure and/or other severe diseases not suitable for CD treatment intervention were further excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Crohn Disease

Condition Hierarchy (Ancestors)

Inflammatory Bowel DiseasesGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The study design was a single-blinded randomized, parallel assignment clinical trial of The study design was single blind and the participants did not know what diet intervention is being given to them.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study design was a single-blinded randomized, parallel assignment clinical trial of CD participants was conducted. Participants were randomized in a 1:1 fashion to either 14-weeks of an EDIP based diet or a normal diet .
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 31, 2021

First Posted

February 3, 2021

Study Start

January 26, 2021

Primary Completion

May 31, 2021

Study Completion

July 31, 2021

Last Updated

February 3, 2021

Record last verified: 2021-01